Skip to content

Intrathecal Chloroprocaine for Lower Limb Arthroplasty

Perioperative Outcomes in Patients Received Spinal Chloroprocaine for Hip or Knee Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05365074
Enrollment
65
Registered
2022-05-09
Start date
2020-01-01
Completion date
2022-03-02
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia

Keywords

chloroprocaine, total hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, spinal anesthesia

Brief summary

This study evaluates the perioperative course in adult patients undergoing total or partial knee arthroplasty, or total hip arthroplasty under chloroprocaine spinal anesthesia.

Detailed description

This study evaluates the failure rate of spinal anesthesia, the duration of surgical anesthesia, the needs for complementary intraoperative analgesia, the time for recovery, the incidence of urinary retention, postoperative nausea and vomiting, and length of stay in the recovery room in patients operated for knee or hip arthroplasty under spinal anesthesia with chloroprocaine 50 mg.

Interventions

Spinal anesthesia with 50 mg of 1% Chloroprocaine

Sponsors

Hospices Civils de Lyon
CollaboratorOTHER
Hôpital de la Croix-Rousse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Inclusion criteria

* adult patients * with spinal anesthesia using 50 mg of chloroprocaine * operated for total knee, unicompartment knee or anterior access hip arthroplasty * in the period of years 2020 - 2021

Exclusion criteria

* expressed disagreement to to participate after receiving information notice

Design outcomes

Primary

MeasureTime frameDescription
Spinal anesthesia failureDay 0proportion of patients with the necessity to convert initially planned spinal anesthesia into general anesthesia

Secondary

MeasureTime frameDescription
Need for sedationDay 0proportion of patients requiring intraoperative sedation for uncomfortable conditions
Surgical block durationDay 0time of regression of sensitive and motor spinal block
PACU analgesia requirementDay 0morphine equivalent requirement in PACU for the postoperative pain
Hemodynamic instabilityDay 0proportion of patients with \>20% changes in blood pressure and ou heart rate comparing to baseline
Postoperative nausea and vomiting24 hoursproportion of patients having nausea and vomiting
Length of stay in recovery roomDay 0Length of stay in recovery room
Urinary retention24 hoursproportion of patients requiring urinary catheter

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026